Acro Biomedical Co annual shares outstanding
2015
2016
2017
2018
2019
2019
2020
2021
2022
2023
2024
2025
Acro Biomedical Co Shares Outstanding History (ACBM)
Acro Biomedical Co reported 60.0M shares outstanding at the end of fiscal 2025.
View full Acro Biomedical Co company overviewAcro Biomedical Co annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 60.0M | 0 | 0.00% |
| 2024 | 2024-12-31 | 60.0M | 0 | 0.00% |
| 2023 | 2023-12-31 | 60.0M | 0 | 0.00% |
| 2022 | 2022-12-31 | 60.0M | 0 | 0.00% |
| 2021 | 2021-12-31 | 60.0M | 12.3M | +25.72% |
| 2020 | 2020-12-31 | 47.8M | 0 | 0.00% |
| 2019 · Dec 31 | 2019-12-31 | 47.8M | 0 | 0.00% |
| 2019 · Sep 30 | 2019-09-30 | 47.8M | 0 | 0.00% |
| 2018 | 2018-09-30 | 47.8M | 100,000 | +0.21% |
| 2017 | 2017-09-30 | 47.7M | 500,000 | +1.06% |
| 2016 | 2016-09-30 | 47.2M | 0 | 0.00% |
| 2015 | 2015-09-30 | 47.2M | — | — |
Acro Biomedical Co quarterly shares outstanding
Q4.15
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 60.0M | 0 | 0.00% |
| Q1 2026 | 2026-03-31 | 60.0M | 0 | 0.00% |
| Q4 2025 | 2025-12-31 | 60.0M | 0 | 0.00% |
| Q3 2025 | 2025-09-30 | 60.0M | 0 | 0.00% |
| Q2 2025 | 2025-06-30 | 60.0M | 0 | 0.00% |
| Q1 2025 | 2025-03-31 | 60.0M | 0 | 0.00% |
| Q4 2024 | 2024-12-31 | 60.0M | 0 | 0.00% |
| Q4 2023 | 2023-12-31 | 60.0M | 0 | 0.00% |
| Q2 2023 | 2023-06-30 | 60.0M | 0 | 0.00% |
| Q1 2023 | 2023-03-31 | 60.0M | 0 | 0.00% |
| Q4 2022 | 2022-12-31 | 60.0M | 0 | 0.00% |
| Q3 2022 | 2022-09-30 | 60.0M | 0 | 0.00% |
| Q2 2022 | 2022-06-30 | 60.0M | 5.5M | +10.10% |
| Q1 2022 | 2022-03-31 | 60.0M | 12.3M | +25.72% |
| Q4 2021 | 2021-12-31 | 60.0M | 12.3M | +25.72% |
| Q3 2021 | 2021-09-30 | 60.0M | 12.3M | +25.72% |
| Q2 2021 | 2021-06-30 | 54.5M | 6.8M | +14.19% |
| Q1 2021 | 2021-03-31 | 47.8M | 0 | 0.00% |
| Q4 2020 | 2020-12-31 | 47.8M | 0 | 0.00% |
| Q3 2020 | 2020-09-30 | 47.8M | 0 | 0.00% |
| Q2 2020 | 2020-06-30 | 47.8M | 0 | 0.00% |
| Q1 2020 | 2020-03-31 | 47.8M | 0 | 0.00% |
| Q4 2019 | 2019-12-31 | 47.8M | 0 | 0.00% |
| Q4 2019 | 2019-09-30 | 47.8M | 0 | 0.00% |
| Q3 2019 | 2019-06-30 | 47.8M | 100,000 | +0.21% |
| Q2 2019 | 2019-03-31 | 47.8M | 100,000 | +0.21% |
| Q1 2019 | 2018-12-31 | 47.8M | 100,000 | +0.21% |
| Q4 2018 | 2018-09-30 | 47.8M | 100,000 | +0.21% |
| Q3 2018 | 2018-06-30 | 47.7M | 500,000 | +1.06% |
| Q2 2018 | 2018-03-31 | 47.7M | −93.8M | −66.31% |
| Q1 2018 | 2017-12-31 | 47.7M | 500,000 | +1.06% |
| Q4 2017 | 2017-09-30 | 47.7M | 500,000 | +1.06% |
| Q3 2017 | 2017-06-30 | 47.2M | 0 | 0.00% |
| Q2 2017 | 2017-03-31 | 141.5M | 94.3M | +200.00% |
| Q1 2017 | 2016-12-31 | 47.2M | 0 | 0.00% |
| Q4 2016 | 2016-09-30 | 47.2M | — | — |
| Q3 2016 | 2016-06-30 | 47.2M | — | — |
| Q2 2016 | 2016-03-31 | 47.2M | — | — |
| Q4 2015 | 2015-09-30 | 47.2M | — | — |
Acro Biomedical Co shares outstanding trends
Over the last five reported fiscal years, Acro Biomedical Co's shares outstanding moved from 47.8M to 60.0M, a change of 12.3M. The latest reported quarter, Q2 2026, shows 60.0M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acro Biomedical Co filings at SEC.gov ↗